Series of novel thiourea and guanidine conjugated β-carbolines along with other analogues of this class were designed and synthesized for in vitro antimalarial activity against Plasmodium falciparum to overcome the threat of resistance to anti-malarial drug. Among them, two guanidine conjugated β-carbolines 7 a and 7 c showed promising activities against both sensitive and resistant strains Pf3D7 and PfINDO with the IC 50 values ranging from 0.6-1.0 μM. The relative activities were further supported by in silico docking and binding studies of the synthesized scaffolds against specific targets, revealing that DHFR and FP3 may act as a potential target for 7 a and 7 c respectively.